source
- Sandoz launches direct-to-consumer platform with growth-hormone biosimilar OmnitropeSandoz announced a direct-to-consumer platform, initially offering Omnitrope, a biosimilar growth hormone for growth disorders. The approach follows a trend among brand-name manufacturers to lower…
- Elevance Health sues CMS, claiming $115 million loss from disputed Medicare Advantage star rating recalculationElevance Health filed a lawsuit in the U.S. District Court for the Southern District of Georgia, alleging that the Centers for Medicare & Medicaid Services (CMS) recalculated its Medicare Advantage…